MESOBLAST MSB
STTComp FA Long
MC $3 BIll.
Pricing for Ryoncil is out and this will lead to also Off label sales. MSB the little Pharma that could, has finally reached it's potential. $10 for LTH STH target $3+ (52 Week High $3.370 to likely be surpassed.)
And, this is all USD
